https://www.indianpharmapost.com/eli-lilly-re-elects-nobel-laureate-carolyn-bertozzi-to-board-185772025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/ascletis-pharma-reports-positive-phase-i-results-for-oral-il-17-inhibitor-185902025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/minghui-pharmaceutical-gets-fda-green-light-for-phase-iii-trials-of-its-therapy-in-thyroid-eye-disease-185892025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/gujarat-kidney-and-super-speciality-to-file-ipo-at-rs108-rs114-per-share-185882025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-cuts-2026-revenue-outlook-amid-covid-19-patent-losses-185872025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-kgaa-launches-chemisphere-app-to-digitize-lab-workflows-185862025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/revvity-unveils-ai-powered-signals-xynthetica-to-accelerate-molecular-and-materials-design-185852025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/bristol-myers-squibb-launches-ai-powered-mosaic-hub-in-mumbai-185842025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/cynata-completes-patient-enrollment-for-phase-2-agvhd-clinical-trial-185832025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-wins-eu-nod-for-self-administered-lupus-drug-saphnelo-185822025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-eir-from-usfda-for-nagpur-injectable-facility-185812025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/remedium-lifecare-is-now-supha-pharmachem-185802025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-secures-exclusive-multi-regional-rights-to-aumolertinib-from-hansoh-pharma-185792025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-secures-sbti-validation-for-emission-reduction-targets-185782025-12-17T00:00:00+05:30always0.9https://www.indianpharmapost.com/vanda-pharmaceuticals-seeks-fda-nod-for-breakthrough-psoriasis-drug-185912025-12-17T00:00:00+05:30always0.9